<DOC>
	<DOCNO>NCT00344513</DOCNO>
	<brief_summary>This program design improve medical care education hospitalize patient heart failure accelerate initiation evidence-based heart failure guideline recommend therapy administer hospital discharge . A registry component focus admission discharge 60- 90-day follow-up design evaluate demographic , pathophysiologic , clinical , treatment , outcome characteristic patient hospitalized heart failure .</brief_summary>
	<brief_title>Organized Program To Initiate Lifesaving Treatment In Hospitalized Patients With Heart Failure ( OPTIMIZE-HF )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>Inclusion criterion : Hospitalized episode worsen heart failure primary cause admission significant heart failure symptom develop hospitalization initial reason admission heart failure . Systolic dysfunction ( LVEF &lt; 40 % ) heart failure symptom set preserve systolic function ( diastolic dysfunction ) . Exclusion criterion : This study exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>registry</keyword>
	<keyword>OPTIMIZE</keyword>
	<keyword>Heart failure</keyword>
	<keyword>OPTIMIZE-HF</keyword>
</DOC>